Latest Breaking News On - Marketing authorization application - Page 13 : vimarsana.com

Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia

Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Advanz pharmaShoshana shendelmanMaeve conneightonDrug administrationHealth indexCommittee for medicinal products human useEuropean medicines agencyTherapeutics incExchange commissionAction dateNew drug applicationClassic galactosemiaPrescription drug user fee actApplied therapeuticsMajor amendmentPriority review

MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

EQS-News: MorphoSys AG / Key word: Annual Report MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update 13.03.2024 / 21:01.

United statesThomas biegiMonjuvi minjuviJulia neugebauerJean paul kressEamonn nolanConstellation pharmaceuticals incCorporate communications investor relationsShare of loss associatesEuropean medicines agencyDevelopment rd expensesGerman federal financial supervisory authority the bafinDrug administrationMorphosys group key figuresCorporate affairsLymphoma society

Prilenia Therapeutics B V : Prilenia Plans to Submit Marketing Authorization Application (MAA) in the EU for Pridopidine in Huntington s Disease

Prilenia Therapeutics B V : Prilenia Plans to Submit Marketing Authorization Application (MAA) in the EU for Pridopidine in Huntington s Disease
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Czech republicNorth lanarkshireUnited kingdomUnited statesStefan klotterMichaelr haydenCommunications teamHuntington study groupSv health investorsInvestment fundEuropean medicines agencyCommittee for medicinal products human useDrug administrationEuropean unionMarketing authorization applicationMedicinal products

Prilenia Plans to Submit Marketing Authorization Application (MAA) in the EU for Pridopidine in Huntington s Disease

Prilenia Plans to Submit Marketing Authorization Application (MAA) in the EU for Pridopidine in Huntington s Disease
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomNorth lanarkshireCzech republicMichaelr haydenCommittee for medicinal products human useProduct serviceSv health investorsEuropean unionDrug administrationInvestment fundEuropean medicines agencyHuntington study groupSubmit marketing authorization applicationMarketing authorization applicationMedicinal products

Missed Out on Eli Lilly? 3 Healthcare Stocks With Big Catalysts on the Horizon

Good news could be in store for all three of these drugmakers.

United statesEli lillyBecky taubEuropean medicine agencyVertex pharmaceuticalsNovo nordiskRegeneron pharmaceuticalsCommittee for medicinal products human useEuropean unionDrug administrationMadrigal pharmaceuticalsMadrigal pharmaceuticalsMedical officer becky taubMarketing authorization applicationMedicinal productsHuman use